Genomic Valley Biotech bulk deals, insider trading and stake changes
BSE: 539206Pharmaceuticals & BiotechnologySmall Cap
Last close ₹37.71up ₹1.79 (4.98%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹35.92.
52-week range of traded prices to 23 Oct 2026
₹20.10Low, 29 Jan 2026₹38.20High, 6 Nov 2025
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 30 Oct 2026 to consider: quarterly results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹12 Cr4,774th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 15 Aug 2026
- 567.4
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 2.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 15 Aug 2026
- 0.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 15 Aug 2026
- 0.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 2,994
Genomic Valley Biotech insider trading
All 17 disclosures on record. The company's own latest disclosure on record is from Dec 2024.Insider trading, all companies
Dec 2024
- YOGESH AGRAWAL₹0.13 Cr13,607 sharesSold · Promoter · 11 Dec 2024 · disclosed 12 Dec · stake 47.17% before, 46.73% after
Oct 2024
- Yogesh Agrawal₹0.21 Cr21,035 sharesSold · Promoter · 29 Oct 2024 · disclosed 6 Nov · stake 47.86% before, 47.17% after
- PARUL AGRAWAL₹0.21 Cr22,000 sharesSold · Director · 17 Oct 2024 · disclosed 18 Oct · held 22,000 before, holds none after
- PARUL AGRAWAL₹0.31 Cr34,000 sharesSold · Director · 14 Oct 2024 · disclosed 15 Oct · stake 3.91% before, 2.80% after
Sep 2024
- PARUL AGRAWAL₹0.89 Cr97,400 sharesSold · Director · 30 Sep 2024 · disclosed 16 Oct · stake 3.91% before, 0.72% after
- PARUL AGRAWAL₹0.15 Cr18,054 sharesSold · Director · 23 Sep 2024 · disclosed 26 Sep · stake 4.50% before, 3.90% after
- PARUL AGRAWAL₹0.12 Cr15,546 sharesSold · Director · 16 Sep 2024 · disclosed 19 Sep · held 1,53,174 before, holds 1,37,628 after
- YOGESH AGRAWAL₹0.11 Cr15,341 sharesSold · Director · 12 Sep 2024 · disclosed 13 Sep · stake 51.60% before, 51.10% after
- YOGESH AGRAWAL₹0.10 Cr14,659 sharesSold · Director · 4 Sep 2024 · disclosed 9 Sep · stake 52.10% before, 51.60% after
- PARUL AGRAWAL₹0.11 Cr16,596 sharesSold · Director · 2 Sep 2024 · disclosed 5 Sep · held 1,77,270 before, holds 1,60,674 after
Aug 2024
- PARUL AGRAWAL₹0.19 Cr28,419 sharesSold · Director · 28 Aug 2024 · disclosed 31 Aug · stake 6.73% before, 5.80% after
- YOGESH AGRAWAL₹0.19 Cr28,900 sharesSold · Director · 21 Aug 2024 · disclosed 5 Sep · stake 53.00% before, 52.15% after
- PARUL AGRAWAL₹0.14 Cr23,242 sharesSold · Director · 21 Aug 2024 · disclosed 23 Aug · stake 7.77% before, 7.01% after
- YOGESH AGRAWAL₹0.16 Cr22,731 sharesSold · Director · 6 Aug 2024 · disclosed 21 Aug · stake 54.00% before, 53.24% after
- PARUL AGRAWAL₹0.27 Cr46,269 sharesSold · Director · 5 Aug 2024 · disclosed 21 Aug · stake 9.29% before, 7.73% after
- YOGESH AGRAWAL₹0.14 Cr26,170 sharesSold · Director · 1 Aug 2024 · disclosed 6 Aug · stake 54.84% before, 53.99% after
Feb 2020
- Yogesh Agrawal₹2.00 Cr13,13,435 sharesReleased · Promoter and Director · 20 Feb 2020 · disclosed 23 Feb · Pledge Release · stake 58.50% before, 58.50% after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Genomic Valley Biotech stake sales and purchases
All 13 disclosures on record.
Oct 2024
- SoldYogesh Agrawal · promoter2.89% of the company88,465 sharesholds 47.86% after25 Oct 2024 · filed under the 2% rule · Market
- SoldHarish Chandra Sharma2.78% of the company85,000 sharesholds 2.02% after18 Oct 2024 · filed under the 2% rule · Market
- SoldParul Agrawal · promoter0.72% of the company22,000 shares18 Oct 2024 · filed under the 2% rule · Market
- SoldParul Agrawal · promoter3.77% of the company1,15,454 sharesholds 0.72% after16 Oct 2024 · filed under the 2% rule · Market
Sep 2024
- SoldParul Agrawal · promoter0.50% of the company15,546 sharesholds 4.50% after17 Sep 2024 · filed under the 2% rule · Market
- SoldParul Agrawal · promoter2.51% of the company76,757 sharesholds 5.26% after2 Sep 2024 · filed under the 2% rule · Market
Aug 2024
- SoldYogesh Agrawal & Parul Agrawal · promoter2.26% of the company69,000 sharesholds 61.02% after20 Aug 2024 · filed under the 2% rule · Market
Mar 2024
- SoldYogesh Agrawal · promoter0.84% of the company25,700 sharesholds 54.84% after31 Mar 2024 · filed under the 2% rule · Market
Dec 2023
- SoldYogesh Agrawal2.13% of the company65,245 sharesholds 55.68% after29 Dec 2023 · filed under the 2% rule · Market
Sep 2018
- AcquiredHarish Chandra Sharma8.18% of the company2,50,000 sharesholds 11.42% after21 Sep 2018 · filed under the 5% rule · Inter-se Transfer
Earlier, Nov 2017 to Dec 2017Hide earlier
Dec 2017
- AcquiredDeepti Aggarwal9.17% of the company2,80,000 sharesholds 11.00% after29 Dec 2017 · filed under the 5% rule · Off Market
- AcquiredAmar Aggarwal & PAC7.22% of the company2,20,500 sharesholds 9.05% after29 Dec 2017 · filed under the 5% rule · Off Market
Nov 2017
- AcquiredYogesh Agrawal · promoter3.45% of the company1,05,250 sharesholds 58.38% after17 Nov 2017 · filed under the 2% rule · Off Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Genomic Valley Biotech bulk deals
Last 12 months, since 23 Oct 2025: 1 bulk deal, ₹0.05 Cr bought and none sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Thursday 22 Jan 20261 firm · ₹0.05 Cr bought · ₹0 soldNet bought ₹0.05 Cr
- BoughtKIRORI MAL SANGHIBought 19,933 at ₹24.990.65% of the company₹0.05 Cr
Friday 25 Oct 20241 firm · ₹0 bought · ₹0.47 Cr soldNet sold ₹0.47 Cr
- SoldYOGESH AGRAWALSold 48,032 at ₹98.461.57% of the company₹0.47 Cr
Wednesday 23 Oct 20241 firm · ₹0 bought · ₹0.21 Cr soldNet sold ₹0.21 Cr
- SoldSATISH KUMAR SHARMASold 21,978 at ₹96.860.72% of the company₹0.21 Cr
Tuesday 22 Oct 20242 firms · ₹0.18 Cr bought · ₹0.20 Cr soldNet sold ₹0.02 Cr
- SoldYOGESH AGRAWALSold 20,000 at ₹99.100.65% of the company₹0.20 Cr
- BoughtPURUSHOTHAMAN SHAJIBought 18,580 at ₹98.450.61% of the company₹0.18 Cr
Monday 21 Oct 20241 firm · ₹0 bought · ₹0.22 Cr soldNet sold ₹0.22 Cr
- SoldSATISH KUMAR SHARMASold 22,322 at ₹99.410.73% of the company₹0.22 Cr
Friday 18 Oct 20243 firms · ₹0.74 Cr bought · ₹0.43 Cr soldNet bought ₹0.32 Cr
- BoughtVIKRAMASHOKKUMARJAINBought 79,000 at ₹94.252.59% of the company₹0.74 Cr
- SoldSATISH KUMAR SHARMASold 25,400 at ₹94.250.83% of the company₹0.24 Cr
- SoldPARUL AGRAWALSold 19,756 at ₹94.250.65% of the company₹0.19 Cr
Wednesday 16 Oct 20242 firms · ₹0.75 Cr bought · ₹0.47 Cr soldNet bought ₹0.28 Cr
- BoughtVIKRAMASHOKKUMARJAINBought 81,000 at ₹92.432.65% of the company₹0.75 Cr
- SoldPARUL AGRAWALSold 50,300 at ₹92.611.65% of the company₹0.47 Cr
Monday 14 Oct 20241 firm · ₹0 bought · ₹0.31 Cr soldNet sold ₹0.31 Cr
- SoldPARUL AGRAWALSold 34,000 at ₹90.251.11% of the company₹0.31 Cr
Friday 11 Oct 20241 firm · ₹0.18 Cr bought · ₹0 soldNet bought ₹0.18 Cr
- BoughtPURUSHOTHAMAN SHAJIBought 20,243 at ₹87.790.66% of the company₹0.18 Cr
Thursday 12 Sep 20241 firm · ₹0 bought · ₹0.11 Cr soldNet sold ₹0.11 Cr
- SoldYOGESH AGRAWALSold 15,341 at ₹73.280.50% of the company₹0.11 Cr
Tuesday 3 Sep 20241 firm · ₹0 bought · ₹0.12 Cr soldNet sold ₹0.12 Cr
- SoldYOGESH AGRAWALSold 16,845 at ₹68.600.55% of the company₹0.12 Cr
Monday 2 Sep 20241 firm · ₹0 bought · ₹0.11 Cr soldNet sold ₹0.11 Cr
- SoldPARUL AGRAWALSold 16,596 at ₹67.450.54% of the company₹0.11 Cr
Friday 30 Aug 20241 firm · ₹0 bought · ₹0.11 Cr soldNet sold ₹0.11 Cr
- SoldPARUL AGRAWALSold 15,947 at ₹66.200.52% of the company₹0.11 Cr
Wednesday 31 Jul 20241 firm · ₹0 bought · ₹0.12 Cr soldNet sold ₹0.12 Cr
- SoldSATISH KUMAR SHARMASold 21,333 at ₹54.040.70% of the company₹0.12 Cr
Tuesday 30 Jul 20241 firm · ₹0 bought · ₹0.15 Cr soldNet sold ₹0.15 Cr
- SoldSATISH KUMAR SHARMASold 27,883 at ₹53.040.91% of the company₹0.15 Cr
Thursday 21 Dec 20231 firm · ₹0 bought · ₹0.06 Cr soldNet sold ₹0.06 Cr
- SoldJAYSUKHLAL TRIBHOVANDAS DOSHISold 20,000 at ₹28.120.65% of the company₹0.06 Cr
Monday 13 Feb 20232 firms · ₹0.04 Cr bought · ₹0.04 Cr soldNet nil
- SoldYOGESH AGRAWALSold 20,005 at ₹21.750.65% of the company₹0.04 Cr
- BoughtSSR FOOTCARE PRIVATE LIMITEDBought 20,000 at ₹21.750.65% of the company₹0.04 Cr
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 22 deals on record since listing on 10 Jul 2015.